| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $255,905 ) |
| 2025 | 2025 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R43HD116653 | Point-of-care Testing (POCT) Tool Development for Critical Oxytocin Measurement | 001 | 1 | NIH | 6/6/2025 | -$636 |
| 2025 | 2025 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R43HD116653 | Point-of-care Testing (POCT) Tool Development for Critical Oxytocin Measurement | 000 | 1 | NIH | 4/3/2025 | $312,817 |
| 2025 | 2023 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R44DA051105 | Rapid Assessment of Illicit Drugs in Wastewater | 000 | 3 | NIH | 1/27/2025 | $0 |
| 2025 | 2022 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R43ES033890 | Low-Cost Amperometric Ozone Monitor for Communities Affected by Wildfires | 000 | 1 | NIH | 3/6/2025 | $0 |
| 2025 | 2021 | GINER INC | 89 Rumford Avenue | Newton | MA | 02466-1311 | MIDDLESEX | USA | 90BISB0018 | High-Energy, Light-Weight Battery to Power Next Generation Wearable Assist Prosthetics | 04 | 2 | ACL | 3/24/2025 | -$56,276 |
| 2025 | 2020 | GINER INC | 89 Rumford Avenue | Newton | MA | 02466-1311 | MIDDLESEX | USA | 90BISB0018 | High-Energy, Light-Weight Battery to Power Next Generation Wearable Assist Prosthetics | 04 | 2 | ACL | 3/24/2025 | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $899,139 ) |
| 2024 | 2024 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R44ES034314 | Field Instrument for Assessment of Arsenic Exposure | 000 | 2 | NIH | 1/31/2024 | $899,139 |
| 2024 | 2023 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R44CA240021 | Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer | 000 | 3 | NIH | 8/15/2024 | $0 |
| 2024 | 2022 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R43ES033890 | Low-Cost Amperometric Ozone Monitor for Communities Affected by Wildfires | 000 | 1 | NIH | 12/5/2023 | $0 |
| 2024 | 2021 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R43DK131910 | At-home Testing of Blood Sodium for Management of Diabetes Insipidus | 000 | 1 | NIH | 11/9/2023 | $0 |
|
 | Issue Date FY: 2023 ( Subtotal = $2,996,924 ) |
| 2023 | 2023 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44DA051105 | Rapid Assessment of Illicit Drugs in Wastewater | 000 | 3 | NIH | 3/1/2023 | $893,058 |
| 2023 | 2023 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44ES034314 | Field Instrument for Assessment of Arsenic Exposure | 000 | 1 | NIH | 2/8/2023 | $845,085 |
| 2023 | 2023 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R43HL170947 | Population monitoring of stress markers in underserved communities | 000 | 1 | NIH | 7/15/2023 | $282,224 |
| 2023 | 2023 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R44ES034314 | Field Instrument for Assessment of Arsenic Exposure | 001 | 1 | NIH | 4/25/2023 | $0 |
| 2023 | 2023 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R44CA240021 | Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer | 002 | 3 | NIH | 8/29/2023 | $997,685 |
| 2023 | 2022 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R43ES033890 | Low-Cost Amperometric Ozone Monitor for Communities Affected by Wildfires | 000 | 1 | NIH | 1/13/2023 | $0 |
| 2023 | 2021 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R44CA240021 | Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer | 001 | 2 | NIH | 5/1/2023 | $0 |
| 2023 | 2021 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R43GH002368 | Electrochemical Assay to Monitor Anti-TB Antibiotics | 02 | 1 | CDC | 9/27/2023 | $0 |
| 2023 | 2021 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R43GH002368 | Electrochemical Assay to Monitor Anti-TB Antibiotics | 02 | 1 | CDC | 9/27/2023 | $0 |
| 2023 | 2021 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | 90BISB0018 | High-Energy, Light-Weight Battery to Power Next Generation Wearable Assist Prosthetics | 02 | 2 | ACL | 6/21/2023 | $0 |
| 2023 | 2021 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | 90BISB0018 | High-Energy, Light-Weight Battery to Power Next Generation Wearable Assist Prosthetics | 03 | 2 | ACL | 9/11/2023 | $0 |
| 2023 | 2021 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44HD095716 | Improved Amputee Quality of Life Enabled by Tailored, Self-Regenerating Energy Storage Device For Powered Prosthetics | 000 | 3 | NIH | 11/22/2022 | $0 |
| 2023 | 2021 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R44HD095716 | Improved Amputee Quality of Life Enabled by Tailored, Self-Regenerating Energy Storage Device For Powered Prosthetics | 001 | 3 | NIH | 4/26/2023 | $0 |
| 2023 | 2020 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | 90BISB0018 | High-Energy, Light-Weight Battery to Power Next Generation Wearable Assist Prosthetics | 02 | 2 | ACL | 6/21/2023 | $0 |
| 2023 | 2020 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | 90BISB0018 | High-Energy, Light-Weight Battery to Power Next Generation Wearable Assist Prosthetics | 03 | 2 | ACL | 9/11/2023 | $0 |
| 2023 | 2020 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44DA041225 | Marijuana Breath Analyzer | 000 | 3 | NIH | 1/19/2023 | $0 |
| 2023 | 2020 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R44DA041225 | Marijuana Breath Analyzer | 001 | 3 | NIH | 5/4/2023 | $0 |
| 2023 | 2019 | GINER INC | 89 RUMFORD AVE | AUBURNDALE | MA | 02466-1311 | MIDDLESEX | USA | R44CA240021 | Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer | 000 | 1 | NIH | 3/13/2023 | -$21,128 |
|
 | Issue Date FY: 2022 ( Subtotal = $1,127,977 ) |
| 2022 | 2022 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44DA051105 | Rapid Assessment of Illicit Drugs in Wastewater | 000 | 2 | NIH | 2/17/2022 | $849,128 |
| 2022 | 2022 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R43ES033890 | Low-Cost Amperometric Ozone Monitor for Communities Affected by Wildfires | 000 | 1 | NIH | 7/19/2022 | $259,613 |
| 2022 | 2021 | Giner, Inc. | 89 Rumford Ave | Newton | MA | 02466-1311 | MIDDLESEX | USA | R43GH002368 | Electrochemical Assay to Monitor Anti-TB Antibiotics | 01 | 1 | CDC | 1/27/2022 | $0 |
| 2022 | 2021 | Giner, Inc. | 89 Rumford Ave | Newton | MA | 02466-1311 | MIDDLESEX | USA | R43GH002368 | Electrochemical Assay to Monitor Anti-TB Antibiotics | 01 | 1 | CDC | 1/27/2022 | $0 |
| 2022 | 2021 | Giner, Inc. | 89 Rumford Ave | Newton | MA | 02466-1311 | MIDDLESEX | USA | 90BISB0018 | High-Energy, Light-Weight Battery to Power Next Generation Wearable Assist Prosthetics | 01 | 2 | ACL | 6/9/2022 | $0 |
| 2022 | 2021 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44CA240021 | Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer | 000 | 2 | NIH | 8/19/2022 | $0 |
| 2022 | 2020 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R43DA051105 | Rapid Assessment of Illicit Drugs in Wastewater | 000 | 1 | NIH | 4/20/2022 | $0 |
| 2022 | 2020 | Giner, Inc. | 89 Rumford Ave | Newton | MA | 02466-1311 | MIDDLESEX | USA | 90BISB0018 | High-Energy, Light-Weight Battery to Power Next Generation Wearable Assist Prosthetics | 01 | 2 | ACL | 6/9/2022 | $0 |
| 2022 | 2020 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44DA041225 | Marijuana Breath Analyzer | 000 | 3 | NIH | 1/24/2022 | $0 |
| 2022 | 2018 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44HD095716 | Improved Amputee Quality of Life Enabled by Tailored, Self-Regenerating Energy Storage Device For Powered Prosthetics | 000 | 1 | NIH | 9/26/2022 | $19,236 |
| 2022 | 2016 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44DK100999 | High Cell Density Bioartificial Pancreas Enabled by Implantable Oxygen Generator | 000 | 3 | NIH | 10/1/2021 | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $2,834,880 ) (Continued on the next page) |
| 2021 | 2021 | Giner, Inc. | 89 Rumford Ave | Newton | MA | 02466-1311 | MIDDLESEX | USA | R43GH002368 | Electrochemical Assay to Monitor Anti-TB Antibiotics | 00 | 1 | CDC | 9/7/2021 | $200,000 |
| 2021 | 2021 | Giner, Inc. | 89 Rumford Ave | Newton | MA | 02466-1311 | MIDDLESEX | USA | 90BISB0018 | High-Energy, Light-Weight Battery to Power Next Generation Wearable Assist Prosthetics | 00 | 2 | ACL | 7/7/2021 | $298,488 |
| 2021 | 2021 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44HD095716 | Improved Amputee Quality of Life Enabled by Tailored, Self-Regenerating Energy Storage Device For Powered Prosthetics | 000 | 3 | NIH | 1/7/2021 | $1,063,168 |
| 2021 | 2021 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R44CA240021 | Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer | 001 | 2 | NIH | 9/3/2021 | $1,002,148 |
| 2021 | 2021 | GINER, INC. | 89 RUMFORD AVE | NEWTON | MA | 02466-1311 | MIDDLESEX | USA | R43DK131910 | At-home Testing of Blood Sodium for Management of Diabetes Insipidus | 000 | 1 | NIH | 9/13/2021 | $259,602 |
| 2021 | 2021 | Giner, Inc. | 89 Rumford Ave | Newton | MA | 02466-1311 | MIDDLESEX | USA | R43GH002368 | Electrochemical Assay to Monitor Anti-TB Antibiotics | 00 | 1 | CDC | 9/7/2021 | $12,083 |
|